Results 171 to 180 of about 2,367,876 (222)
Some of the next articles are maybe not open access.
Diagnosis and management of chronic myelomonocytic leukemia
Current Hematologic Malignancy Reports, 2008Chronic myelomonocytic leukemia is a heterogeneous hematologic malignancy classified among the mixed myelodysplastic/myeloproliferative diseases by the World Health Organization because of its myelodysplastic and myeloproliferative characteristics.
F. Onida, M. Beran
openaire +2 more sources
Chronic myelomonocytic leukemia
Current Treatment Options in Oncology, 2002Chronic myelomonocytic leukemia (CMML) has dysplastic and proliferative features. The median age of patients with CMML is 70 years; the median survival is approximately 2 years. Various chemotherapy regimens have been used with only modest success. When the proliferative phase prevails, hydroxyurea is the treatment of choice.
openaire +2 more sources
Cytogenetics of chronic myelomonocytic leukemia
Cancer Genetics and Cytogenetics, 1986In a retrospective multicenter study by the Groupe Français de Cytogénétique Hématologique, chromosome investigation was undertaken in 120 cases of chronic myelomonocytic leukemia, which was diagnosed in accordance with the French-American-British (FAB) criteria.
openaire +2 more sources
Chronic Myelomonocytic Leukemia
2007Owing to its variable pathologic features and clinical course, chronic myelomonocytic leukemia (CMML) is both a diagnostic and a therapeutic challenge. The French-American-British (FAB) classification system included CMML as one of the five categories of myelodysplastic syndrome (1), and its definition of CMML as a disease characterized by absolute ...
openaire +2 more sources
Chronic myelomonocytic leukemia diagnosis and management
Leukemia, 2021Chronic myelomonocytic leukemia (CMML) is a rare, heterogeneous myeloid malignancy classified as a myelodysplastic syndromes/myeloproliferative neoplasm (MDS/MPN) overlap syndrome by the World Health Organization (WHO). Its initial presentation can be incidental or associated with myelodysplastic or myeloproliferative symptoms and up to 20% of patients
Chan, Onyee +2 more
openaire +3 more sources
ATYPICAL LEUKEMIA — Relation to Chronic Myelomonocytic Leukemia —
Acta Pathologica Japonica, 1980An autopsy case of a 71‐year‐old man with atypical leukemia was reported. The interesting points in this case were the followings: (1) three clonal proliferations; granulocytic, monocytic, megakaryocytic; (2) abnormality of several kinds of blood cells; (3) phagocytosis of granular leucocytes within megakaryocytes; (4) elevation of anti‐EB virus ...
K, Nemoto, Y, Ohnishi
openaire +2 more sources
Clonal Architecture of Chronic Myelomonocytic Leukemias
Blood, 2013Key Points Early clonal dominance may distinguish chronic myelomonocytic leukemia from other chronic myeloid neoplasms with similar gene mutations. Early dominance of TET2-mutated cells in the hematopoietic tissue promotes myeloid differentiation skewing toward the granulomonocytic line.
Claude Preudhomme +2 more
exaly +4 more sources
Blood, 2015
Abstract Introduction. Development of abnormal Philadelphia (Ph) negative clones following treatment of chronic myeloid leukemia (CML) patients with imatinib has been observed in 3 to 9% of patients. Here we report on a 77 year old male diagnosed with CML that responded to imatinib treatment and subsequently developed chronic ...
Jamshid S Khorashad +11 more
openaire +1 more source
Abstract Introduction. Development of abnormal Philadelphia (Ph) negative clones following treatment of chronic myeloid leukemia (CML) patients with imatinib has been observed in 3 to 9% of patients. Here we report on a 77 year old male diagnosed with CML that responded to imatinib treatment and subsequently developed chronic ...
Jamshid S Khorashad +11 more
openaire +1 more source
Colonic infiltration with chronic myelomonocytic leukemia
Nature Clinical Practice Gastroenterology & Hepatology, 2007A 75-year-old female presented with a 1 month history of non-bloody diarrhea, associated with abdominal cramping and urgency. Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously and managed expectantly by monitoring the patient's complete blood count.
Andelka D, LoSavio +2 more
openaire +2 more sources
Subacute and Chronic Myelomonocytic Leukemia
1981Subacute and chronic myelomonocytic leukemia have been previously described under different names. Recent works have underlined the most common features of these syndromes [3, 8, 10, 16, 28, 29]. Since numerous other papers refer to them, giving additional etiological and biological data, this talk will focus on certain specific topics.
openaire +2 more sources

